The treatment of AML: current status and novel approaches (Q36269943)

13 August 2017

1 reference

title

The treatment of AML: current status and novel approaches (English)

1 reference

13 August 2017

Alan K Burnett

1

1 reference

13 August 2017

publication date

1 September 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

10 Suppl 1

1 reference

13 August 2017

page(s)

50-53

1 reference

13 August 2017

cites work

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331389773

Acute myeloid leukemia: treatment of adults under 60 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331389773

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331389773

Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Par

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331389773

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331389773

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331389773

A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331389773

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331389773

A feasibility study of simultaneous administration of gemtuzumab ozogamicin with intensive chemotherapy in induction and consolidation in younger patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331389773

Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331389773

Emerging treatments in acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331389773

SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331389773

Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331389773

Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331389773

Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245330512331389773

10.1080/10245330512331389773

21 January 2018

Identifiers

DOI

1 reference

release_lrmithuaabc4tgikt3gm52rfiy

13 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lrmithuaabc4tgikt3gm52rfiy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference